Treatment effect estimates varied depending on the definition of the provider prescribing preference-based instrumental variables

Journal of Clinical Epidemiology

Volumn 65, Issue 2, 2012, Pages 155-162

  Ionescu Ittu, Raluca ^a   Abrahamowicz, Michal ^a,b,c   Pilote, Louise ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Administrative databases; Atrial fibrillation; Comparative effectiveness; Instrumental variables; Mortality; Prescribing preference based instruments

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; EMPIRICAL RESEARCH; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL;

ATRIAL FIBRILLATION; HOSPITALS; HUMANS; PHYSICIANS; RESEARCH DESIGN; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84855346610     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2011.06.012     Document Type: Article

References (47)

1. Walker AM. Confounding by indication. Epidemiology 1996;7:335-6.
2. Crystal S, Akincigil A, Bilder S, Walkup JT. Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies. Med Care 2007;45:S58-65.
3. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol 2009;62:1226-32.
4. Hernan MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology 2006;17:360-72. (Pubitemid 44305508)
5. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol 2009;62:1233-41.
6. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006;17:268-75.
7. Hennessy S, Leonard CE, Palumbo CM, Shi X, Ten Have TR. Instantaneous preference was a stronger instrumental variable than 3- and 6-month prescribing preference for NSAIDs. J Clin Epidemiol 2008;61:1285-8.
8. Brookhart MA, Rassen JA, Wang PS, Dormuth C, Mogun H, Schneeweiss S. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care 2007;45:S116-22.
9. Kawaguchi T, Ieiri N, Yamazaki S, Hayashino Y, Gillespie B, Miyazaki M, et al. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria. Nephrology (Carlton);15:116-23.
10. Pratt N, Roughead EE, Ryan P, Salter A. Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments. Pharmacoepidemiol Drug Saf 2010;19:699-707.
11. Rassen JA, Mittleman MA, Glynn RJ, Alan Brookhart M, Schneeweiss S. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention. Eur Heart J 2010;31:561-72.
12. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008;358:771-83. (Pubitemid 351284455)
13. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C,Wang PS. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007;176:627-32. (Pubitemid 46426056)
14. Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum 2006;54:3390-8. (Pubitemid 44737149)
15. Ionescu-Ittu R, Delaney JA, Abrahamowicz M. Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study. Pharmacoepidemiol Drug Saf 2009;18:562-71.
16. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009;30:2969-2977c.
17. Snow V, Weiss KB, LeFevre M, McNamara R, Bass E, Green LA, et al. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139:1009-17.
18. Wyse D, Simpson C. 2004 Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation. Rate control vs rhythm controldecision making. Can J Cardiol 2005;21(Suppl B):15B-8B.
19. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. (Pubitemid 35417773)
20. de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 2005;165:258-62. (Pubitemid 40216276)
21. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002;144:290-6. (Pubitemid 34879653)
22. Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005;36:1776-81. (Pubitemid 41098778)
23. Levy AR, Tamblyn RM, Fitchett D, McLeod PJ, Hanley JA. Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol 1999;15:1277-82. (Pubitemid 30006767)
24. Powell H, Lim LL, Heller RF. Accuracy of administrative data to assess comorbidity in patients with heart disease. An Australian perspective. J Clin Epidemiol 2001;54:687-93. (Pubitemid 32594854)
25. Pelargonio G, Prystowsky EN. Rate versus rhythm control in the management of patients with atrial fibrillation. Nat Clin Pract Cardiovasc Med 2005;2:514-21. (Pubitemid 41670342)
26. Postal Code Conversion File. Catalogue 92I0153XCE. In: Statistics Canada. 2002.
27. Havranek EP, Wolfe P, Masoudi FA, Rathore SS, Krumholz HM, Ordin DL. Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure. Arch Intern Med 2004;164:1186-91. (Pubitemid 39030354)
28. O'Connor GT, Quinton HB, Traven ND, Ramunno LD, Dodds TA, Marciniak TA, et al. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 1999;281:627-33. (Pubitemid 29098063)
29. Nair H, Manchanda P, Bhatia T. Research paper no. 1970: asymmetric peer effects in physician prescription behaviour: the role of opinion leaders. In: Research Paper Series Standford Graduate School of Business. Stanford, CA: Standford Graduate School of Business; 2006.
30. Gelman A, Hill J. Causal inference using more advanced models. In: Data analysis using regression and multilevel/hierarchical models. 1st ed. New York: Cambridge University Press; 2007:215-26.
31. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010;19:537-54.
32. Stock JH, Yogo M. Testing for weak instruments in linear IV regression. Massachusetts, MA: National Bureau of Economic Research, Inc.; 2002.
33. Larcker DF, Rusticus TO. On the use of instrumental variables in accounting research. J Accounting Economics 2009;49:186-205.
34. Staiger D, Stock J. Instrumental variables regression with weak instruments. Econometrica 1997;65:557-86. (Pubitemid 127466159)
35. Bound J, Jaeger DA, Baker RM. Problems with instrumental variables estimation when the correlation between the instruments and the endogenous explanatory variable is weak. J Am Stat Assoc 1995;90:443-50.
36. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology 2006;17:260-7.
37. Burgess S, Thompson SG, and the CRP Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 2011;40:755-64.
38. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001;104:2118-50. (Pubitemid 33028911)
39. Prystowsky E, Katz A. Atrial fibrillation. In: EJ T, editor. Textbook of cardiovascular medicine. Philadelphia, PA: Lippincott-Raven; 2002:1403-8.
40. Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York, NY: John Wiley and Sons, Inc.; 2000.
41. Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, Brookhart MA. Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol 2009;169:273-84.
42. Terza JV, Bradford WD, Dismuke CE. The use of linear instrumental variables methods in health services research and health economics: a cautionary note. Health Serv Res 2008;43:1102-20. (Pubitemid 351623957)
43. Angrist J, Imbens G, Rubin D. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;9:444-72.
44. Clarke P, Windmeijer F. CMPO working paper no. 09/209: Instrumental variable estimators for binary outcomes. Bristol, UK: Bristol Institute of Public Affairs; 2009.
45. Abraham NS, Castillo DL, Hartman C. National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use. Aliment Pharmacol Ther 2008;28:97-106. (Pubitemid 351782812)
46. Dore DD, Seeger JD, Arnold Chan K. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin 2009;25:1019-27.
47. Prasad PA, Coffin SE, Leckerman KH, Walsh TJ, Zaoutis TE. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J 2008;27:1083-8.